𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study

✍ Scribed by G. S. Ungvari; Helen F. K. Chiu; Lok Yee Chow; Benjamin S. T. Lau; Wai Kwong Tang

Publisher
Springer
Year
1999
Tongue
English
Weight
74 KB
Volume
142
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Orodispersible sublingual piribedil to a
Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo-controlled, randomized, double-blind, cross-over study
✍ Olivier Rascol; Jean-Philippe Azulay; Olivier Blin; Anne-Marie Bonnet; Christine πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 247 KB πŸ‘ 1 views

## Abstract S90049, a novel sublingual formulation of the non‐ergoline D~2~‐D~3~ agonist piribedil, has a pharmacokinetic profile promising to provide rapid relief on motor signs in Parkinson's disease (PD). We assessed the efficacy and safety of S90049 in aborting OFF episodes responding to subcut

Sulfasalazine in the treatment of juveni
Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
✍ Marion A. J. van Rossum; Theo J. W. Fiselier; Marcel J. A. M. Franssen; Aeilko H πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 987 KB

Objective. To assess the efficacy, tolerability, and safety of sulfasalazine (SSZ) in the treatment ofjuvenile chronic arthritis (JCA). Methods. We conducted a 24-week randomized, placebo-controlled, double-blind, multicenter study of patients with active JCA of both oligoarticular and polyarticula